MedPage Today on MSN
First Gene Therapy Approved for Hearing Loss
Maker says Otarmeni will be offered for free in the U.S.
TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results